Skip to main content
    M

    MannKind Corp (MNKD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.07
    +0.11 (+2.91%)

    Market Cap: $1.27B

    Last updated: Nov 17, 2026 at 4:40 PM ET

    MannKind Corp (MNKD) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    MannKind (MNKD) has a market cap of $1.27B and an enterprise value of $1.55B. Revenue grew 31.74% over the last 12 months from the 12 months before. Its share count is up 4.36% from a year earlier.

    Total Valuation

    Enterprise value is 21.87% above the market cap, as debt exceeds cash.

    Market Cap$1.27B
    Enterprise Value$1.55B
    Latest price (Nov 17, 2026)$4.07

    Key Dates

    The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 24, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 3.55% in the quarter ended Sep 30, 2026 and grew 7.90% a year over 2 years.

    Shares Outstanding320.18M
    Shares Change (YoY)+4.36%
    Shares Change (QoQ)+3.55%
    Share Count Growth (2Y CAGR)+7.90%

    Valuation Ratios

    The price to sales ratio is 3.2x. Its year-end P/S ranged from 1.7x to 20.8x from 2016 to 2025.

    P/S Ratio3.2x
    Forward P/S2.9x

    Price Statistics

    The stock is down 19.57% over 52 weeks and trades 14.01% above its 50-day average.

    Beta (1Y)0.99
    52-Week Change-19.57%
    1-Month Change+31.72%
    3-Month Change-7.39%
    6-Month Change+37.50%
    5-Year Change-25.69%
    10-Year Change+67.79%
    Total Return (1Y)-19.57%
    Total Return (3Y CAGR)+2.31%
    Total Return (5Y CAGR)-2.88%
    Return vs SPY (1Y)-31.12%
    Max Drawdown (1Y)-63.29%
    Max Drawdown (3Y)-69.35%
    Sharpe Ratio (1Y)-0.29
    Correlation with SPY (1Y)0.18
    50-Day Average$3.57
    200-Day Average$3.63
    52-Week Range$2.23 to $6.51
    RSI (14 Days)61.7
    Average Volume (20 Days)3.36M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.22x current liabilities.

    Current Ratio2.22x
    Quick Ratio1.77x
    Interest Coverage0.83x

    Returns and Efficiency

    Return on invested capital is -10.38% over the last 12 months, against a 5-year average of -84.40%.

    Return on Assets (ROA)-10.35%
    Return on Invested Capital (ROIC)-10.38%
    Return on Capital Employed (ROCE)-5.07%
    ROA (5Y Average)-9.91%
    ROIC (5Y Average)-84.40%
    Asset Turnover0.68x
    Inventory Turnover2.16x
    Receivables Turnover9.81x
    Cash Conversion Cycle160 days

    Scores

    MNKD has an Altman Z-Score of -4.63, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score-4.63
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $413.37M over the last 12 months.

    Revenue$413.37M
    Revenue Growth (YoY)+31.74%
    Gross Profit$313.17M
    Operating Income-$11.89M
    Pretax Income-$79.61M
    Net Income-$74.82M
    EBITDA-$3.96M
    EBIT-$31.16M
    Reported EPS (TTM)-$0.20

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$41.28M
    Total Debt$319.45M
    Net Debt$278.17M
    Net Debt Per Share$0.87
    Working Capital$131.95M
    Shareholder Equity-$37.27M
    Tangible Book Value-$109.79M
    Total Assets$722.62M
    Total Liabilities$759.88M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $12.16M of capital spending, operating cash flow left -$78.41M of free cash flow.

    Operating Cash Flow-$66.24M
    Capital Expenditures$12.16M
    Free Cash Flow-$78.41M
    FCF Per Share-$0.24
    Depreciation and Amortization$27.45M
    Share Repurchases$5.84M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -2.88%, against a 5-year average of -17.14%.

    Gross Margin75.76%
    Operating Margin-2.88%
    Pretax Margin-19.26%
    Net Margin-18.10%
    EBITDA Margin-0.96%
    EBIT Margin-7.54%
    FCF Margin-18.97%
    Gross Margin (5Y Average)61.46%
    Operating Margin (5Y Average)-17.14%
    Net Margin (5Y Average)-37.91%

    Growth

    Revenue grew 51.80% a year over 3 years.

    Revenue Growth (3Y CAGR)+51.80%
    Revenue Growth (5Y CAGR)+39.89%

    Revenue and profit by year

    Dividends and Yields

    MNKD does not pay a dividend. Its free cash flow yield is -6.02%.

    FCF Yield-6.02%
    Buyback Yield0.45%
    Shareholder Yield0.45%

    Stock Splits

    The last split was a 1-for-5 reverse split on Mar 3, 2017.

    Last Split DateMar 3, 2017
    Split TypeReverse split
    Split Ratio1:5

    Peer Position

    Against 8 similar companies, MNKD has the 7th highest P/S.

    P/S Ratio3.2x vs 10.2x median
    ROIC-10.38% vs -34.91% median
    Revenue Growth (Trailing 4 Quarters, YoY)+31.74% vs +12.82% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 22.01% and EPS growth at 50.00% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+22.01%
    EPS Growth Forecast (2Y CAGR)+50.00%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About MNKD

    What is MNKD's market cap?

    MannKind has a market cap of $1.27B. Its enterprise value, which adds debt and subtracts cash, is $1.55B.

    How many shares of MNKD are outstanding?

    MannKind has 320.18M shares outstanding. The count is up 4.36% from a year earlier.

    Does MNKD pay a dividend?

    No. MannKind does not pay a dividend.

    How much debt does MNKD have?

    MannKind has $319.45M of total debt and $41.28M of cash and equivalents, a net debt position of $278.17M.